Advertisement

The Nutshell

Daily News Roundup

Most Recent

Neuroscientist claims stolen data

By | July 2, 2008

A prominent neuroscientist is accusing two former researchers in his lab of taking data without his permission and publishing misleading interpretations of them against his wishes. linkurl:Nikos Logothetis,;http://www.kyb.mpg.de/~nikos director of the Max Planck Institute for Biological Cybernetics in Tubingen, Germany, says that two former researchers working in his lab took fMRI data from monkey brain scans without his permission and made misleading interpretations in a paper published this m

6 Comments

Sluggish economy hits biotech

By | July 2, 2008

Not one single venture-backed US company completed an linkurl:initial public offering;http://www.the-scientist.com/article/display/18293/ (IPO) in the second quarter of 2008, according to a linkurl:report;http://www.nvca.org/pdf/Q2_08_Exits_Release.pdf released yesterday (July 1) by the National Venture Capital Association, and the news means that small, privately-funded biotech companies may find it difficult to stay afloat in these uncertain economic times. "Companies will either disappear or

0 Comments

Brain's neuronal nexus mapped

By | July 1, 2008

A structural brain map -- the most detailed to date -- provides support for a controversial theory of a "default" state of brain activity, and could bring key insights into the physiological basis of illnesses such as schizophrenia, depression, and Alzheimer's disease. Researchers have identified a set of axonal pathways in the human cerebral cortex that forms structural "core" of the cortex -- a neuronal nexus that acts as the main relay station between disparate brain regions involved in cogn

0 Comments

Diet drug duke-out

By | July 1, 2008

When you're a pharmaceutical company hoping to turn a profit on a controversial product, your work never stops, it would appear. Although, I suppose that's true of any pharmaceutical company nowadays... GlaxoSmithKline, marketers of the over-the-counter weight-loss drug alli, which we linkurl:profiled;http://www.nj.com/news/index.ssf/2008/06/consumers_face_a_bewildering_a.html in last month's issue, is asking the FDA to force weight-loss supplement sellers to conduct clinical trials

7 Comments

UK gives third hybrid embryo ok

By | July 1, 2008

British biologists have received government approval to create the world's first human stem cells from hybrid embryos, part pig, part human. The Warwick Medical School team, led by linkurl:Justin St. John;http://www2.warwick.ac.uk/fac/med/staff/stjohn of the Clinical Sciences Research Institute, was granted the country's third animal-human embryo license from the linkurl:Human Fertilisation and Embryology Authority,;http://www.hfea.gov.uk/ which goes into effect today (July 1). The team plan

0 Comments

Govt settles anthrax suit

By | June 30, 2008

A former US army biodefense researcher who was a "person of interest" in the still-unsolved case of the 2001 anthrax letters and who sued the government, claiming the investigation ruined his reputation, will receive a $5.8 million settlement from the Justice Department. The FBI turned its attention on the researcher, linkurl:Steven J. Hatfill,;http://www.the-scientist.com/article/display/20669/ in 2002 as part of its investigation of the mysterious anthrax case that caused the death of five p

3 Comments

Birds of a feather

By | June 26, 2008

In the largest ever study of bird genetics, a five-year international collaboration has redrawn the avian family tree. The report, published in Science this week (June 27), proposes surprising new classifications and suggests that environmental adaptations arose multiple times in bird history. "It's an important paper that represents a very comprehensive study," said linkurl:Larry Martin,;http://www.nhm.ku.edu/paleontology/ldmartin.htm Curator of the National History Museum at the University

0 Comments

NIH funding increase stalled

By | June 26, 2008

A spending bill that would increase the National Institutes of Health 2009 budget by $1.2 billion over President Bush's linkurl:proposed NIH budget;http://www.the-scientist.com/blog/display/54277/ was sidelined by partisan wrangling in the full House Committee on Appropriations today (June 26). "[Bush's] budget would result in 6,000 medical research scientists who will no longer be able to get their research funded," said Representative linkurl:David Obey;http://www.the-scientist.com/article/di

1 Comment

Stem cell patents final in US, debated in Europe

By | June 26, 2008

After three contentious stem cell patents were upheld in the US earlier this year, the debate over one of the patents continues this week in Europe. The Board of Appeal at the European Patent Office heard a dispute on Tuesday (June 24) on awarding a patent to the US stem cell technology. The technology in question is covered by one of the three patents held by the Wisconsin Alumni Research Foundation (WARF). It includes methods to culture and maintain primate embryonic stem cells derived from

0 Comments

Conflict probe turns to Stanford

By | June 25, 2008

The irascible conflict of interest hunter, linkurl:Senator Charles Grassley;http://www.the-scientist.com/blog/display/54561/ (R-IA), has set his sights on a Stanford University psychiatrist who's running a federally funded clinical trial on a drug made by the same company in which he owns millions of dollars in stock. The psychiatrist is linkurl:Alan Schatzberg,;http://med.stanford.edu/profiles/Alan_Schatzberg and he is the chair of the psychiatry department at Stanford's School of Medicine. Sc

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Rainin Instrument
Rainin Instrument
Advertisement
PITTCON
PITTCON
Life Technologies